Community Pharmacy Assisting in Total Cardiovascular Health

Not Applicable

• Conditions: Statin Therapy; Adherence

• Registration Number: NCT01509014
• Lead Sponsor: University of Saskatchewan

Brief Summary

Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence.

The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03
• Primary Completion: 2011-11
• Status Verified: 2012-01
• Study Completion: 2012-01
• Study First Submitted: 2012-01-09
• Study First Submitted QC: 2012-01-11
• Last Update Submitted: 2012-01-11
• Study First Posted: 2012-01-12
• Last Update Posted: 2012-01-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2250

Inclusion Criteria

• Pharmacies must fill at least 85 statin prescriptions in a six-week period
• CPATCH intervention was given priority over other study initiatives offered by the pharmacy
• All members of pharmacy staff provided informed consent

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription	6 months	All statin dispensations are captured by the prescription drug plan database. Mean adherence will be measured using the proportion of days covered (sum of days supply for statin prescriptions during study period divided by the number of days of observation). PDC will be adjusted for any days subject was hospitalized during study period.,

Secondary Outcome Measures

Name	Time	Method
Proportion of new statin users with adherence greater than or equal to 80%	6 months
Persistence with statin use among patients with a minimum of 12 months of follow-up	6 months

Trial Locations

Locations (1)

College of Pharmacy and Nutrition, University of Saskatchewan; 🇨🇦 Saskatoon, Saskatchewan, Canada